ADXN - Addex Therapeutics Ltd Sotuvning sof marjinal rentabelligi

Addex Therapeutics Ltd - ADXN emitenti grafik logotipi

Addex Therapeutics markaziy nerv tizimi uchun allosterik modulyatorlarni ishlab chiqishga e'tibor qaratadi va kapital xarajatlarsiz foyda o'sishini ta'minlash uchun patent litsenziyalashidan foydalanadi. Bashorat qiluvchi savdo marjalari daromadning foyda ulushini kuzatish imkonini beradi, -8312.80 qiymati esa ushbu ko'rsatkichning balansini aks ettiradi. Dori vositalarini yetkazib berish paytidagi qat'iy harorat nazorati testlarning xavfsizligini ta'minlaydi. Tajribali rahbariyat global hamkorlarni muvaffaqiyatli jalb qilmoqda va neyro-portfelni ishlab chiqishni muvofiqlashtirmoqda.

Addex (ADXN) Sof foyda marjasi: 04.07.2022 - 19.11.2026 davri uchun

ADXN (Addex Therapeutics): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi statistikasi:
Kompaniyaning fundamental baholanishi:Addex Therapeutics Ltd. - ADXN
Addex tayyor mahsulotlari

Portfel tahlilchisi ushbu ko'rsatkichdan fundamental sektor yetakchilarini stagnatsiyaga uchragan aktivlardan ajratish uchun foydalanadi. Ushbu metrika sof foydani umumiy tushumning ulushi sifatida o'lchaydi va biznesning yakuniy operatsion samaradorligini aks ettiradi. Addex Therapeutics (ADXN) uchun ushbu hisob-kitob nevrologik buzilishlarni davolash uchun patentlangan molekulalarni monetizatsiya qilish qobiliyatini tasdiqlaydi. Tushumning foydaga yuqori konversiyasi biznes modelining barqarorligini ko'rsatadi. Tijorat va ishlab chiqarish faoliyatining sof marjasini tahlil qilish orqali investor aksiyalar qiymatining uzoq muddatli o'sish potentsialini baholaydi.

Addex Therapeutics (ADXN) raqobatchilari

BIIB: Sotuvning sof marjinal rentabelligi|Sof marja Neurocrine Biosciences Inc (NBIX)|RGC (Regencell Corp) - Sotuvning sof marjinal rentabelligi|AXSM: Sof foyda normasi|Sof marja acadia-pharm.com (ACAD)|Sotuvning sof marjinal rentabelligi Xenon Pharmaceuticals (XENE)|Sof marja Viking Therapeutics VKTX|Sof foyda normasi SUPN|CPRX - Sof marja|Sof marja Denali Therapeutics|HRMY: Sotuvning sof marjinal rentabelligi|Biohaven - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi AMLX|Trevi Therapeutics, Inc. (TRVI) - Kompaniya sotuv marjasi|Sof foyda bo'yicha sotuv rentabelligi PRAX (Praxis Medicines)|Anavex Corp - Sotuvning sof rentabelligi|Sof marja CeriBell CBLL|Kompaniya sotuv marjasi Prothena Biosciences (PRTA)|ALEC: Sof foyda bo'yicha sotuv rentabelligi|ANNX - Sotuvning sof marjinal rentabelligi|Omeros Corp. (OMER) - Sof marja|Sof marja Neurogene Inc. (NGNE)|Sof foyda bo'yicha sotuv rentabelligi ACIU|Sof marja VYGR|Sof marja Neumora (NMRA)|SCLX - Sof marja|Sotuvning sof marjinal rentabelligi TVGN (Tevogen Bio Holdings Inc.)|Sof foyda normasi ACOG|Cognition Therapeutics Inc. - Sotuvning sof marjinal rentabelligi|IKT - Sotuvning sof marjinal rentabelligi|SAVA: Sotuvning sof marjinal rentabelligi|Assertio Holdings, Inc. - Sof foyda normasi|COYA (Coya) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi VTGN (Vistagen Therapeutics)|Sof marja Ovid Rx (OVID)|Acumen Pharmaceuticals - Sotuvning sof rentabelligi|Sof marja CervoMed, Inc. CRVO|Sotuvning sof marjinal rentabelligi Alterity Therapeutics ATHE|CLNN: Sof foyda bo'yicha sotuv rentabelligi|PEPG (pepgen.com) - Sotuvning sof rentabelligi|Jupiter Neurosciences Inc (JUNS) - Sof marja|Relmada Therapeutics - Sof foyda normasi|ANVS (Annovis Bio Inc) - Sotuvning sof marjinal rentabelligi|GRCE: Sof foyda normasi|Sof marja Firefly Neuroscience Inc (AIFF)|KLTO (ANEW Medical) - Sof foyda normasi|Sof marja neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Sof marja|MTVA: Sof foyda bo'yicha sotuv rentabelligi|NeurAxis, Inc (NRXS) - Sof foyda bo'yicha sotuv rentabelligi|HSDT: Sotuvning sof marjinal rentabelligi|PASG - Kompaniya sotuv marjasi|Sof marja Neuphoria Therapeutics, Inc.|Sof marja NERV|Sotuvning sof marjinal rentabelligi ATHA|ALZN (Alzamend Neuro Inc.) - Sof foyda normasi|Sotuvning sof marjinal rentabelligi CYCN (cyclerion.com)|Sof foyda bo'yicha marjinallik Protagenic|KTTA: Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi CRGT (cortigent.com)|ATXI: Sotuvning sof marjinal rentabelligi|BCLI (BrainStorm Cell Therapeutics) - Sof marja|CARA (Cara Therapeutics Inc.) - Sotuvning sof marjinal rentabelligi|Sof marja CHRO|Sof foyda bo'yicha sotuv rentabelligi ELYM (Eliem Therapeutics)|Sof marja ITCI (Intra-Cellular Therapies Inc.)|Sotuvning sof marjinal rentabelligi LBPH (Longboard Pharma)|Sotuvning sof marjinal rentabelligi Marinus Pharmaceuticals Inc MRNS|NKGen Biotech Corp - Sotuvning sof marjinal rentabelligi|Sof foyda normasi NRBO (NeuroBo Pharma)|SAGE (Sage Therapeutics, Inc) - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof rentabelligi SNPX|Sof foyda bo'yicha sotuv rentabelligi TRVN|Sof marja VIGL|Sotuvning sof marjinal rentabelligi WENA|Kompaniya sotuv marjasi Cerevel